GGrantIndex
Sort

326,823 grants matching clinical trial

Experimental Therapy for Brain Tumors

$2,461,078
John H Sampson · Duke University · P01 · FY2019 · CA

Neuronal anatomy, connectivity, and phenotypic innervation of the knee joint

$2,460,714
Brendan Hl Lee · Baylor College Of Medicine · UC2 · FY2025 · AR

Vitamin Intervention for Stroke Prevention (VISP)

$2,460,696
Wake Forest University Health Sciences · R01 · FY2003 · NS

Genomics for Kidney Transplantation

$2,460,555
Scripps Research Institute · U19 · FY2004 · AI

Taking Our Shot: Extended-Release Naltrexone as Opioid Overdose Pre-Exposure Prophylaxis (PrEP) in People Using Stimulants Living With or At Risk of HIV

$2,460,000
Ayesha A Appa · University Of California, San Francisco · DP2 · FY2024 · DA

Vascular Subphenotypes of Lung Disease

$2,459,371
Mark Thomas Gladwin · University Of Pittsburgh At Pittsburgh · P01 · FY2015 · HL

CTSA INFRASTRUCTURE FOR CLINICAL TRIALS

$2,459,361
Steven E Reis · University Of Pittsburgh At Pittsburgh · UL1 · FY2008 · RR

CANCER CENTER SUPPORT GRANT

$2,459,346
Gerold Bepler · Wayne State University · P30 · FY2014 · CA

DENVER AUTOIMMUNITY CENTER OF EXCELLENCE

$2,459,269
University Of Colorado Denver · U19 · FY2002 · AI

DATA COORDINATING CENTER FOR DESPR

$2,458,966
· N01 · FY2010 · HD

Core C: Biosecurity Core

$2,458,772
James W. Leduc · University Of Texas Med Br Galveston · UC7 · FY2022 · AI

Emory WIHS CRS - Longitudinal Cohort

$2,458,733
Ighovwerha Ofotokun · Emory University · U01 · FY2014 · AI

Mobilizing Community Systems to Engage Families in Early ASD Detection & Services

$2,458,680
Amy M Wetherby · Florida State University · R01 · FY2014 · MH

LOW BACK PAIN--A MULTICENTER RANDOMIZED TRIAL

$2,458,674
Dartmouth College · U01 · FY2002 · AR

Heartland Cancer Research NCORP

$2,458,574
James L Wade · Decatur Memorial Hospital · UG1 · FY2015 · CA

Brain Tumor Clinical and Clinical Research Program

$2,458,438
Mark Gilbert · Division Of Basic Sciences - Nci · ZID · FY2018 · CA

Improving the Clinical Effectiveness and Understanding of the Biophysical Basis

$2,457,927
Theodore S Hong · Massachusetts General Hospital · U19 · FY2017 · CA

Pharmacogenomics and Risk of Cardiovascular Disease

$2,457,795
Ronald M Krauss · Children'S Hospital & Res Ctr At Oakland · U19 · FY2013 · HL

Ohio Valley Node-Network (OVNN) of the NIDA Clinical Trials Network

$2,457,513
T John Winhusen · University Of Cincinnati · UG1 · FY2019 · DA

COVID-19 Clinical Support and Research

$2,457,478
Adrian McDermott · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI

Endocannabinoids And Energy Homeostasis

$2,457,470
George Kunos · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2011 · AA

Dietary and Hormonal Determinants of Cancer in Women

$2,457,338
Meir J Stampfer · Brigham And Women'S Hospital · P01 · FY2015 · CA

Targeting Inflammation and Alloimmunity in Heart Transplant Recipients with Tocilizumab

$2,457,204
Joren C Madsen · Massachusetts General Hospital · U01 · FY2020 · AI

SPORE in Lung Cancer

$2,457,135
Paul A Bunn · University Of Colorado Denver · P50 · FY2009 · CA

Genetics and Epigenetics of Cardiovascular Disease

$2,457,031
Gary Gibbons · National Human Genome Research Institute · ZIA · FY2023 · HG